Increased expression of inflammatory cytokines and matrix metalloproteinases in pseudophakic corneal edema

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 6, 2005, Pages 1940-1947

  Shoshani, Yochai ^a   Pe'er, Jacob ^a   Doviner, Victoria ^a   Frucht Pery, Joseph ^a   Solomon, Abraham ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FORMALDEHYDE; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PARAFFIN; STROMELYSIN; VASCULOTROPIN; INTERLEUKIN DERIVATIVE; VASCULOTROPIN A;

ADULT; AGE; AGED; ANGIOGENESIS; ARTICLE; BLISTER; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; DESQUAMATION; DIGITAL IMAGING; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PATHOLOGY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PSEUDOPHAKIA; STAINING; TISSUE SECTION; WOUND HEALING; ENZYME IMMUNOASSAY; IATROGENIC DISEASE; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CORNEAL EDEMA; EPITHELIUM, CORNEAL; HUMANS; IATROGENIC DISEASE; IMMUNOENZYME TECHNIQUES; INTERLEUKINS; KERATOPLASTY, PENETRATING; MATRIX METALLOPROTEINASES; MIDDLE AGED; PSEUDOPHAKIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 22144437774     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1203     Document Type: Article

References (62)

1. Cohen EJ, Brady SE, Leavitt K, et al. Pseudophakic bullous keratopathy. Am J Ophthalmol. 1988;106:264-269.
2. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea. 2000;19:813-816.
3. Kenyon KR. The synthesis of basement membrane by the corneal epithelium in bullous keratopathy. Invest Ophthalmol Vis Sci. 1969;8:156-168.
4. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996;37:997-1007.
5. Weng J, Mohan RR, Li Q, Wilson SE. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1β expression in the cornea. Cornea. 1997;16:465-471.
6. Kinoshita S, Adachi W, Sotozono C, et al. Characteristics of the human ocular surface epithelium. Prog Retin Eye Res. 2001;20:639-673.
7. Torres PF, Kijlstra A. The role of cytokines in corneal immunopathology. Ocul Immunol Inflamm. 2001;9:9-24.
8. Rosenbaum JT, Planck ST, Huang XN, et al. Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci. 1995;36:2151-2155.
9. Saghizadeh M, Chwa M, Aoki A, et al. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res. 2001;73:179-189.
10. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. AmJRespir Cell Mol Biol. 1992;7:120-125.
11. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
12. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163-176.
13. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature. 1994;370:555-557.
14. Li D-Q, Shang TY, Kim HS, et al. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:2928-2936.
15. Kervick GN, Pflugfelder SC, Haimovici R, et al. Paracentral rheumatoid corneal ulceration: clinical features and cyclosporine therapy. Ophthalmology. 1992;99:80-88.
16. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001;132:8-13.
17. Smith VA, Rishmawi H, Hussein H, Easty DL. Tear film MMP accumulation and corneal disease. Br J Ophthalmol. 2001;85:147-153.
18. Solomon A, Li D-Q, Lee S-B, Tseng SCG. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2000;41:2154-2163.
19. Meller D, Li D-Q, Tseng SCG. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1β and tumor necrosis factor-α. Invest Ophthalmol Vis Sci. 2000;41:2922-2929.
20. Albaugh G, Kann B, Strande L, et al. Nicotine induces endothelial TNF-alpha expression, which mediates growth retardation in vitro. J Surg Res. 2001;99:381-384.
21. Wilson SE, He Y-G, Lloyd SA. EGF, EGF receptor, basic FGF, TGF-beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756-1765.
22. Cubitt CL, Lausch RN, Oakes JE. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci. 1995;36:330-336.
23. Elner VM, Strieter RM, Pavilack MA, et al. Human corneal interleukin-8: IL-1 and TNF-induced gene expression and secretion. Am J Pathol. 1991;139:977-988.
24. Chedid M, Rubin JS, Csaky KG, Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem. 1994;269:10753-10757.
25. Wilson SE, Walker JW, Chwang EL, He Y-G. Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561.
26. Kovalchuk LV, Khoroshilova-Maslova IP, Gankovskaya LV, et al. Natural complex of cytokines is a potent stimulant to posttraumatic regeneration in rabbit cornea. J Ocul Pharmacol Ther. 1996;12:271-279.
27. van Setten GB. Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance. Acta Ophthalmol Scand. 1997;75:649-652.
28. Joussen AM, Poulaki V, Mitsiades N, et al. VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci. 2003;44:117-123.
29. Lai CM, Spilsbury K, Brankov M, et al. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res. 2002;75:625-634.
30. Mastyugin V, Mosaed S, Bonazzi A, et al. Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear. Curr Eye Res. 2001;23:1-10.
31. Li A, Dubey S, Varney ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003;170:3369-3376.
32. Spandau UH, Toksoy A, Verhaart S, et al. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol. 2003;121:825-831.
33. Natarajan K, Rajala MS, Chodosh J. Corneal IL-8 expression following adenovirus infection is mediated by c-Src activation in human corneal fibroblasts. J Immunol. 2003;170:6234-6243.
34. Tran MT, Lausch RN, Oakes JE. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:3871-3877.
35. Strieter RM, Kunkel SL, Elner VM, et al. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol. 1992;141:1279-1284.
36. Tanaka T, Kanai H, Sekiguchi K, et al. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol. 2000;32:1955-1967.
37. Valter MM, Wiestler OD, Pietsche T, Pietsch T. Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF. Int J Dev Neurosci. 1999;17:565-577.
38. Moses MA. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells. 1997;15:180-189.
39. Clark AF. New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci. 1998;39:2514-2516.
40. Li D-Q, Lee S-B, Gunja-Smith Z, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by cultured pterygium head fibroblasts. Arch Ophthalmol. 2001;119:71-80.
41. Leonardi A, Brun P, Abatangelo G, et al. Tear levels and activity of matrix metalloproteinase (MMP)1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052-3058.
42. Matsubara M, Girard MT, Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinases family in the remodelling cornea. Dev Biol. 1991;147:425-439.
43. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290(suppl):S12-S23.
44. Fini ME, Parks WC, Rinehart WB, et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 1996;149:1287-1302.
45. Afonso AA, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with IL-1α concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506-2512.
46. Kenney MC, Chwa M, Alba A, et al. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998;17:238-246.
47. Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001;73:449-459.
48. Jasser MZ, Mitchell PG, Cheung HS. Induction of stromelysin-1 and collagenase synthesis in fibrinochondrocytes by tumor necrosis factor-alpha. Matrix Biol. 1994;14:241-249.
49. Mitchell PG, Cheung HS. Protein kinase regulation of tumor necrosis factor alpha stimulated collagenase and stromelysin message levels in chondrocytes. Biochem Biophys Res Commun. 1993;196:1133-1142.
50. Mohan MJ, Seaton T, Mitchell J, et al. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry. 2002;41:9462-9469.
51. Catrina AI, Lampa J, Ernestam S, et al. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford). 2002;41:484-489.
52. Schulz S, Schagdarsurengin U, Suss T, et al. Relation between the tumor necrosis factor-alpha (TNF-alpha) gene and protein expression, and clinical, biochemical, and genetic markers: age, body mass index and uric acid are independent predictors for an elevated TNF-alpha plasma level in a complex risk model. Eur Cytokine Netw. 2004;15:105-111.
53. Chorinchath BB, Kong LY, Mao L, McCallum RE. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol. 1996;156:1525-1530.
54. Han D, Hosokawa T, Aoike A, Kawai K. Age-related enhancement of tumor necrosis factor (TNT) production in mice. Mech Ageing Dev. 1995;84:39-54.
55. Girard MT, Matsubara M, Fini ME. Transforming growth factor-β and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441-2454.
56. Librach CL, Feigenbaum SL, Bass KE, et al. Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem. 1994;269:17125-17131.
57. Nelimarkka LO, Nikkari ST, Ravanti LS, et al. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro. Matrix Biol. 1998;17:293-304.
58. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998;435:29-34.
59. Matsubara M, Zieske JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 1991;32:3221-3237.
60. Kenney MC, Chwa M. Abnormal extracellular matrix in corneas with pseudophakic bullous keratopathy. Cornea. 1990;9:115-121.
61. Solomon A, Li D-Q, Li D-Q, et al. Doxycycline inhibition of the interleukin-1 system in the corneal epithelium. Invest Ophthalmol Vis Sci. 2000;41:2544-2557.
62. Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000;41:1703-1709.